West Pharmaceutical Services | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Align Technology USD 696.94M 15.17M 2024-12
Avanos Medical USD 98M 5.1M 2024-12
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Charles River Laboratories USD 319.68M 48.09M 2024-12
Cooper Companies USD 660.2M 17.5M 2025-01
Dentsply International USD 455M 40M 2024-12
Haemonetics USD 196.57M 5.37M 2024-12
ICU Medical USD 227.26M 22.41M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
IQVIA Holdings USD 1.38B 0 2024-12
J&J USD 15.41B 102M 2024-12
Medtronic USD 5.52B 49M 2025-01
Merit Medical Systems USD 172.98M 15.45M 2024-12
Neogen USD 113.33M 8.4M 2024-11
Quidel USD 326.1M 26.2M 2024-12
Repligen USD 77.49M 220K 2024-09
Solventum Corp 1.12B 46M 2024-12
STAAR Surgical USD 31.65M 36.84M 2024-12
Terumo JPY 145.12B 5.66B 2024-12
West Pharmaceutical Services USD 273.6M 8.9M 2024-12



West Pharmaceutical Services Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.